CSI Focus D-HF

The field of device based therapy in heart failure continues to develop at a fast pace. Advancements in ventricle restoration strategies, device based strategies to improve cardiac output and new monitoring systems only represent a small proportion of the potential for cutting edge technologies and emerging platforms in this new field. The 5th D-HF congress will take place in Paris, December 13 – 14, 2019.

AimRADIAL & PCI

Three-day conference about technical and medical innovations in radial access and percutaneous coronary intereventions (PCI).

The rapid evolution of digital technology and its impact on the prevention and treatment of heart disease is the subject of a new digital summit organized by the European Society of Cardiology (ESC). The ESC Digital Summit will be held Oct. 5-6, 2019, in Tallinn, Estonia.

Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug Administration (FDA) clearance for reprocessing the PentaRay Nav Eco High-Density mapping catheter manufactured by Biosense Webster. The PentaRay is a key medical device in atrial fibrillation (AF) procedures, one of the fastest growing and most expensive procedures in hospitals today, according to the company. Hospitals utilizing the reprocessed PentaRay and other expensive single-use labeled cardiology devices can save thousands of dollars on each AF procedure, potentially opening the procedure up for more patients.

European Society of Cardiology (ESC) Digital Summit

FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.

The new Post-Acute Care Heart Failure Certification offered from the American Heart Association (AHA) provides education and resources to skilled nursing facilities to reduce the hospital readmissions for heart failure patients.

A study of a procedure developed at Henry Ford Health System shows inducing a heart attack in patients with heart disease could be a viable option for patients in need of mitral valve replacement.

The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next generation of real-world research on behalf of cardiovascular disease and diabetes patients around the world.

Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound systems. With Release 5.0, both systems now include automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct.1 Together, the new applications provide clinicians with the means to confidently evaluate the heart’s function, increasing diagnostic confidence for patients with pulmonary hypertension, congenital heart disease, coronary disease and heart failure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now